Cas:347331-78-6 1-(4-bromophenyl)-2,5-dimethylpyrrole-3-carbaldehyde manufacturer & supplier

Chemical Name:1-(4-bromophenyl)-2,5-dimethylpyrrole-3-carbaldehyde

CAS.NO:347331-78-6

Synonyms:1-(4-Bromophenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde

Molecular Formula:C₁₃H₁₂BrNO

Molecular Weight:278.14400

HS Code:2933990090

Physical and Chemical Properties:

Melting point:117-119ºC

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:22.00000

Exact Mass:277.01000

LogP:3.66910

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(4-Bromophenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-Bromophenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-Bromophenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde Use and application,1-(4-Bromophenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde technical grade,usp/ep/jp grade.

Related News: The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. 1-(4-bromophenyl)-2,5-dimethylpyrrole-3-carbaldehyde manufacturer You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. 1-(4-bromophenyl)-2,5-dimethylpyrrole-3-carbaldehyde supplier You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. 1-(4-bromophenyl)-2,5-dimethylpyrrole-3-carbaldehyde vendor The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. 1-(4-bromophenyl)-2,5-dimethylpyrrole-3-carbaldehyde factory At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase.